ID   M3K7_RAT                Reviewed;         606 AA.
AC   P0C8E4;
DT   04-NOV-2008, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 1.
DT   29-MAY-2024, entry version 117.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 7;
DE            EC=2.7.11.25 {ECO:0000250|UniProtKB:O43318};
GN   Name=Map3k7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 28-331.
RC   TISSUE=Hypothalamus, and Prostate;
RG   Amgen EST program;
RT   "Amgen rat EST program.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 351-606.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine kinase which acts as an essential component
CC       of the MAP kinase signal transduction pathway. Plays an important role
CC       in the cascades of cellular responses evoked by changes in the
CC       environment. Mediates signal transduction of TRAF6, various cytokines
CC       including interleukin-1 (IL-1), transforming growth factor-beta (TGFB),
CC       TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR),
CC       tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Once
CC       activated, acts as an upstream activator of the MKK/JNK signal
CC       transduction cascade and the p38 MAPK signal transduction cascade
CC       through the phosphorylation and activation of several MAP kinase
CC       kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7.
CC       These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases
CC       (JNKs); both p38 MAPK and JNK pathways control the transcription
CC       factors activator protein-1 (AP-1). Independently of MAP2Ks and p38
CC       MAPKs, acts as a key activator of NF-kappa-B by promoting activation of
CC       the I-kappa-B-kinase (IKK) core complex. Mechanistically, recruited to
CC       polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and
CC       TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of
CC       IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B
CC       activation. In osmotic stress signaling, plays a major role in the
CC       activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5
CC       capsid-specific restriction activity. Phosphorylates RIPK1 at 'Ser-321'
CC       which positively regulates RIPK1 interaction with RIPK3 to promote
CC       necroptosis but negatively regulates RIPK1 kinase activity and its
CC       interaction with FADD to mediate apoptosis. Phosphorylates STING1 in
CC       response to cGAMP-activation, promoting association between STEEP1 and
CC       STING1 and STING1 translocation to COPII vesicles.
CC       {ECO:0000250|UniProtKB:O43318, ECO:0000250|UniProtKB:Q62073}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC         Evidence={ECO:0000250|UniProtKB:O43318};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25; Evidence={ECO:0000250|UniProtKB:O43318};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O43318};
CC   -!- ACTIVITY REGULATION: Activated by pro-inflammatory cytokines and in
CC       response to physical and chemical stresses, including osmotic stress,
CC       oxidative stress, arsenic and ultraviolet light irradiation. Activated
CC       by 'Lys-63'-linked polyubiquitination and by autophosphorylation.
CC       Association with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 promotes activation
CC       through autophosphorylation, whereas PPM1B/PP2CB, PP2A and PPP6C
CC       dephosphorylation leads to inactivation. Ceramides are also able to
CC       activate MAP3K7/TAK1. {ECO:0000250|UniProtKB:O43318}.
CC   -!- SUBUNIT: Can form homodimer. Binds both upstream activators and
CC       downstream substrates in multimolecular complexes. Interacts with
CC       TAB1/MAP3K7IP1, TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3. Identified in the
CC       TRIKA2 complex composed of MAP3K7/TAK1, TAB1/MAP3K7IP1 and
CC       TAB2/MAP3K7IP2. Interacts with PPM1L and PPM1B/PP2CB. Interaction with
CC       PP2A and PPP6C leads to its repressed activity. Interacts with TRAF6
CC       and TAB1/MAP3K7IP1; during IL-1 signaling. Interacts with TAOK1 and
CC       TAOK2; interaction with TAOK2 interferes with MAP3K7 interaction with
CC       IKKA, thus preventing NF-kappa-B activation. Interacts with DYNC2I2
CC       (via WD domains). Interacts with CYLD and RBCK1. Interacts with TGFBR1;
CC       induces MAP3K7/TAK1 activation by TRAF6. Interacts with MAPK8IP1 and
CC       SMAD6. Interacts with isoform 1 of VRK2. Interacts with DAB2; the
CC       interaction is induced by TGF-beta stimulation and may mediate TGF-beta
CC       stimulated JNK activation. Interacts with TRIM5. Part of a complex
CC       containing ITCH, NDFIP1 and MAP3K7. Interacts with PLEKHM1 (via N- and
CC       C-terminus). Found in a complex with SH3RF1, RAC2, MAP2K7/MKK7,
CC       MAPK8IP1/JIP1, MAPK8/JNK1 and MAPK9/JNK2. Interacts with SASH1 (By
CC       similarity). Interacts with RIPK1 (By similarity).
CC       {ECO:0000250|UniProtKB:O43318, ECO:0000250|UniProtKB:Q62073}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic
CC       side {ECO:0000250}. Note=Although the majority of MAP3K7/TAK1 is found
CC       in the cytosol, when complexed with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2,
CC       it is also localized at the cell membrane. {ECO:0000250}.
CC   -!- PTM: Association with TAB1/MAP3K7IP1 promotes autophosphorylation at
CC       Ser-192 and subsequent activation. Association with TAB2/MAP3K7IP2,
CC       itself associated with free unanchored Lys-63 polyubiquitin chain,
CC       promotes autophosphorylation and subsequent activation of MAP3K7.
CC       Dephosphorylation at Ser-192 by PPM1B/PP2CB and at Thr-187 by PP2A and
CC       PPP6C leads to inactivation (By similarity). {ECO:0000250}.
CC   -!- PTM: 'Lys-48'-linked polyubiquitination at Lys-72 is induced by
CC       TNFalpha, and leads to proteasomal degradation. Undergoes 'Lys-48'-
CC       linked polyubiquitination catalyzed by ITCH. 'Lys-63'-linked
CC       polyubiquitination at Lys-158 by TRIM8 does not lead to proteasomal
CC       degradation but contributes to autophosphorylation and activation.
CC       Deubiquitinated by CYLD, a protease that selectively cleaves 'Lys-63'-
CC       linked ubiquitin chains. {ECO:0000250|UniProtKB:O43318,
CC       ECO:0000250|UniProtKB:Q62073}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03040223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CB583299; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CB771642; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CK481792; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; DN936104; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001101390.2; NM_001107920.2.
DR   RefSeq; XP_003750801.1; XM_003750753.4.
DR   AlphaFoldDB; P0C8E4; -.
DR   SMR; P0C8E4; -.
DR   BioGRID; 260325; 6.
DR   IntAct; P0C8E4; 1.
DR   STRING; 10116.ENSRNOP00000007654; -.
DR   GlyGen; P0C8E4; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P0C8E4; -.
DR   PhosphoSitePlus; P0C8E4; -.
DR   jPOST; P0C8E4; -.
DR   PaxDb; 10116-ENSRNOP00000007654; -.
DR   Ensembl; ENSRNOT00000007654.6; ENSRNOP00000007654.4; ENSRNOG00000005724.6.
DR   Ensembl; ENSRNOT00055017015; ENSRNOP00055013688; ENSRNOG00055010068.
DR   Ensembl; ENSRNOT00060023757; ENSRNOP00060018909; ENSRNOG00060013880.
DR   Ensembl; ENSRNOT00065008681; ENSRNOP00065006143; ENSRNOG00065005799.
DR   GeneID; 313121; -.
DR   KEGG; rno:313121; -.
DR   UCSC; RGD:1309438; rat.
DR   AGR; RGD:1309438; -.
DR   CTD; 6885; -.
DR   RGD; 1309438; Map3k7.
DR   eggNOG; KOG0192; Eukaryota.
DR   GeneTree; ENSGT00940000157785; -.
DR   HOGENOM; CLU_000288_7_41_1; -.
DR   InParanoid; P0C8E4; -.
DR   OMA; ARTQCFA; -.
DR   OrthoDB; 653199at2759; -.
DR   PhylomeDB; P0C8E4; -.
DR   TreeFam; TF105116; -.
DR   Reactome; R-RNO-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-RNO-4086398; Ca2+ pathway.
DR   Reactome; R-RNO-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-RNO-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-RNO-5357956; TNFR1-induced NF-kappa-B signaling pathway.
DR   Reactome; R-RNO-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-9020702; Interleukin-1 signaling.
DR   Reactome; R-RNO-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-RNO-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-RNO-9645460; Alpha-protein kinase 1 signaling pathway.
DR   Reactome; R-RNO-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   PRO; PR:P0C8E4; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000005724; Expressed in ovary and 19 other cell types or tissues.
DR   GO; GO:0140672; C:ATAC complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:RGD.
DR   GO; GO:0035173; F:histone kinase activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:1990450; F:linear polyubiquitin binding; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004707; F:MAP kinase activity; ISO:RGD.
DR   GO; GO:0004708; F:MAP kinase kinase activity; ISO:RGD.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:RGD.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0120283; F:protein serine/threonine kinase binding; IDA:RGD.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; IPI:RGD.
DR   GO; GO:0005114; F:type II transforming growth factor beta receptor binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0043276; P:anoikis; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0060348; P:bone development; ISO:RGD.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IDA:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IDA:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0007252; P:I-kappaB phosphorylation; ISS:UniProtKB.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038173; P:interleukin-17A-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0038172; P:interleukin-33-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISS:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; IDA:RGD.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:0060546; P:negative regulation of necroptotic process; ISO:RGD.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:1902443; P:negative regulation of ripoptosome assembly involved in necroptotic process; ISO:RGD.
DR   GO; GO:0001841; P:neural tube formation; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0038066; P:p38MAPK cascade; ISO:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; IMP:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; IMP:RGD.
DR   GO; GO:0045787; P:positive regulation of cell cycle; IMP:RGD.
DR   GO; GO:0045793; P:positive regulation of cell size; IMP:RGD.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; ISS:UniProtKB.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0002726; P:positive regulation of T cell cytokine production; ISO:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:1990776; P:response to angiotensin; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; ISO:RGD.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISO:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   CDD; cd14058; STKc_TAK1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR049637; MAP3K7.
DR   InterPro; IPR017421; MAP3K7-like.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR46716; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; 1.
DR   PANTHER; PTHR46716:SF1; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF038168; MAPKKK7; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Cell membrane; Cytoplasm; Isopeptide bond; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Stress response;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation.
FT   CHAIN           1..606
FT                   /note="Mitogen-activated protein kinase kinase kinase 7"
FT                   /id="PRO_0000353138"
FT   DOMAIN          36..291
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..300
FT                   /note="Interaction with MAPK8IP1"
FT                   /evidence="ECO:0000250"
FT   REGION          301..338
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          354..391
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          443..492
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        303..338
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        354..382
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        443..475
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        156
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         42..50
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         63
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         184
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O43318"
FT   MOD_RES         187
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O43318"
FT   MOD_RES         192
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O43318"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43318"
FT   MOD_RES         389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         455
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43318"
FT   CROSSLNK        72
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O43318"
FT   CROSSLNK        158
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q62073"
FT   CROSSLNK        209
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q62073"
SQ   SEQUENCE   606 AA;  67200 MW;  E24987277A616DCD CRC64;
     MSTASAASSS SSSSASEMIE APSQVLNFEE IDYKEIEVEE VVGRGAFGVV CKAKWRAKDV
     AIKQIESESE RKAFIVELRQ LSRVNHPNIV KLYGACLNPV CLVMEYAEGG SLYNVLHGAE
     PLPYYTAAHA MSWCLQCSQG VAYLHSMQPK ALIHRDLKPP NLLLVAGGTV LKICDFGTAC
     DIQTHMTNNK GSAAWMAPEV FEGSNYSEKC DVFSWGIILW EVITRRKPFD EIGGPAFRIM
     WAVHNGTRPP LIKNLPKPIE SLMTRCWSKD PSQRPSMEEI VKIMTHLMRY FPGADEPLQY
     PCQYSDEGQS NSATSTGSFM DIASTNTSNK SDTNMEQVPA TNDTIKRLES KLLKNQAKQQ
     SDSGRLSLGA SRGSSVESLP PTSEGKRMSA DMSEIEARIV ATTAYTKPKR GHRKTASFGN
     ILDVPEIVIS GNGQPRRRSI QDLTVTGTEP GQVSSRSSSP SVRMITTSGP TSEKPARSLP
     WTPDDSTDTN GSDNSIPMAY LTLDHQLQPL APCPNSKESM AVFEQHCKMA QEYMKVQTEI
     ALLLQRKQEL VAELDQDEKD QQNTSRLVQE HKKLLDENKS LSTYYQQCKK QLEVIRSQQQ
     KRQGTS
//
